At the news
? BEARISHIMPACT 6/10 EFFECT filed Jun 11, 2026 at 00:15 ET
Forte Biosciences' universal shelf registration (File No. 333-296425) became effective on June 10, 2026, enabling the company to offer and sell up to $500M in securities. This opens the door for potential capital raises to fund Phase 2 trials and operations, creating a persistent dilution overhang given the company's $344M market cap and accelerating cash burn.
- Shelf registration on Form S-3 became effective June 10, 2026 (File No. 333-296425).
- Company registered up to $500M in securities (common, preferred, debt, warrants, units).
- Market cap is ~$344M; shelf represents ~145% of current market cap.
- Q1 2026 cash & equivalents fell to $58.2M from $77.0M; net loss was $22.1M.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access